High-grade B-cell Lymphoma (HGBL)
Oncology·MeSH: Lymphoma, Large B-Cell, Diffuse
Prevalence
56.0 / 100K
Incidence
19.6 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target High-grade B-cell Lymphoma (HGBL)?
There are 1 clinical trial targeting High-grade B-cell Lymphoma (HGBL) tracked by BioSniper.
What is the prevalence of High-grade B-cell Lymphoma (HGBL)?
The estimated prevalence of High-grade B-cell Lymphoma (HGBL) is approximately 56.0 per 100,000 population.
Deep-dive into High-grade B-cell Lymphoma (HGBL)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis